• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丹麦胸膜感染人群中RAPID评分的验证

Validation of the RAPID score in a Danish population with pleural infection.

作者信息

Hansen Linette Yde, Falster Casper, Bedawi Eihab, Bhatnagar Rahul, Bodtger Uffe, Laursen Christian B

机构信息

Odense Respiratory Research Unit (ODIN), Department of Clinical Research, University of Southern Denmark.

Department of Emergency Medicine, Goedstrup Hospital, Herning.

出版信息

Dan Med J. 2024 Jul 4;71(8):A01240071. doi: 10.61409/A01240071.

DOI:10.61409/A01240071
PMID:40116449
Abstract

INTRODUCTION

The incidence of pleural infection, a condition associated with increased mortality, is rising internationally. The RAPID (renal, age, purulence, infection source and dietary factor) score is a prognostic tool designed to stratify patients into risk categories based on five clinical baseline parameters. The aim of the study was to validate the RAPID score as a tool for assessment of prognosis, in the form of mortality, in patients with pleural infection in a Danish setting.

METHODS

This was a retrospective observational cohort study including all patients coded with an International Classification of Diseases, version 10 (ICD-10) code for pleural infection (DJ86 Pyothorax) at a regional University Hospital in a five-year period. Medical records were reviewed retrospectively, RAPID scores were calculated and study participants were stratified into risk groups: low (RAPID scores: 0-2), medium (RAPID scores: 3-4) and high (RAPID scores: 5-7). The primary outcome was three-month mortality. Secondary outcomes were 12-month mortality, length of hospital stay, failure of initial medical treatment and surgical intervention.

RESULTS

Overall mortality at three months was 18.0%. Mortality according to RAPID risk category was as follows: Low risk 2.4% (95% confidence interval (CI): 0.1-12.6), medium risk 17.0% (95% CI: 7.7-30.8) and high risk 39.4% (95% CI 22.9-57.9). Hazard ratios for three-month mortality, with low risk as reference, were 7.5 (95% CI: 0.9-60.1; p = 0.057) for medium risk and 20.6 (95% CI: 2.7-157.6; p = 0.004) for high risk.

CONCLUSION

The findings of this study support the use of the RAPID score as a prognostic tool for assessment of mortality risk in patients with pleural infection in Danish healthcare.

FUNDING

None.

TRIAL REGISTRATION

Not relevant.

摘要

引言

胸膜感染的发病率在国际上呈上升趋势,该病症与死亡率增加相关。RAPID(肾脏、年龄、脓性、感染源和饮食因素)评分是一种预后工具,旨在根据五个临床基线参数将患者分为不同风险类别。本研究的目的是在丹麦环境中验证RAPID评分作为评估胸膜感染患者死亡率预后工具的有效性。

方法

这是一项回顾性观察队列研究,纳入了五年期间在一家地区大学医院被编码为国际疾病分类第10版(ICD - 10)胸膜感染代码(DJ86脓胸)的所有患者。对医疗记录进行回顾性审查,计算RAPID评分,并将研究参与者分为风险组:低风险(RAPID评分:0 - 2)、中风险(RAPID评分:3 - 4)和高风险(RAPID评分:5 - 7)。主要结局是三个月死亡率。次要结局是十二个月死亡率、住院时间、初始治疗失败和手术干预。

结果

三个月时的总体死亡率为18.0%。根据RAPID风险类别划分的死亡率如下:低风险2.4%(95%置信区间(CI):0.1 - 12.6),中风险17.0%(95%CI:7.7 - 30.8),高风险39.4%(95%CI 22.9 - 57.9)。以低风险为参照,中风险三个月死亡率的风险比为7.5(95%CI:0.9 - 60.1;p = 0.057),高风险为20.6(95%CI:2.7 - 157.6;p = 0.004)。

结论

本研究结果支持将RAPID评分用作丹麦医疗保健中胸膜感染患者死亡风险评估的预后工具。

资金来源

无。

试验注册

不相关。

相似文献

1
Validation of the RAPID score in a Danish population with pleural infection.丹麦胸膜感染人群中RAPID评分的验证
Dan Med J. 2024 Jul 4;71(8):A01240071. doi: 10.61409/A01240071.
2
Evaluation of the RAPID score as a predictor of postoperative morbidity and mortality in patients undergoing pulmonary decortication for stage III pleural empyema.评估RAPID评分对Ⅲ期胸膜腔脓胸行肺纤维板剥脱术患者术后发病率和死亡率的预测价值。
Clinics (Sao Paulo). 2024 Apr 11;79:100356. doi: 10.1016/j.clinsp.2024.100356. eCollection 2024.
3
Risk Stratification in Patients with Complicated Parapneumonic Effusions and Empyema Using the RAPID Score.应用 RAPID 评分对复杂性类肺炎旁胸腔积液和脓胸患者进行风险分层。
Lung. 2018 Oct;196(5):623-629. doi: 10.1007/s00408-018-0146-2. Epub 2018 Aug 11.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Outcome and clinical characteristics in pleural empyema: a retrospective study.胸膜腔积脓的治疗结果及临床特征:一项回顾性研究
Scand J Infect Dis. 2011 Jul;43(6-7):430-5. doi: 10.3109/00365548.2011.562527. Epub 2011 Mar 2.
6
Intrapleural tissue plasminogen activator and deoxyribonuclease in complex pleural effusion and empyema, clinical outcomes, and predictors.胸膜内组织型纤溶酶原激活剂和脱氧核糖核酸酶治疗复杂性胸腔积液和脓胸的临床结局及预测因素
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251343711. doi: 10.1177/17534666251343711. Epub 2025 May 30.
7
Prospective validation of the RAPID clinical risk prediction score in adult patients with pleural infection: the PILOT study.RAPID临床风险预测评分在成年胸膜感染患者中的前瞻性验证:PILOT研究
Eur Respir J. 2020 Nov 26;56(5). doi: 10.1183/13993003.00130-2020. Print 2020 Nov.
8
Predicting Long-Term Outcomes in Pleural Infections. RAPID Score for Risk Stratification.预测胸膜感染的长期预后。风险分层的 RAPID 评分。
Ann Am Thorac Soc. 2015 Sep;12(9):1310-6. doi: 10.1513/AnnalsATS.201505-272OC.
9
Pleural infection: a retrospective study of clinical outcome and the correlation to known etiology, co-morbidity and treatment factors.胸膜感染:临床结局及其与已知病因、合并症和治疗因素相关性的回顾性研究
BMC Pulm Med. 2018 Oct 12;18(1):160. doi: 10.1186/s12890-018-0726-1.
10
Incidence, length of stay, and prognosis of hospitalized patients with pleural empyema: a 15-year Danish nationwide cohort study.胸腔积脓住院患者的发病率、住院时间及预后:一项为期15年的丹麦全国队列研究
Chest. 2014 Jan;145(1):189-192. doi: 10.1378/chest.13-1912.